Meningococcal B and Meningitis: A Growing Concern Down Under
A recent surge in meningococcal B and meningitis cases in the United Kingdom, tragically resulting in the deaths of two young individuals, has brought this serious infectious disease into sharp focus. In Kent, south-east England, five new cases of meningitis have been identified in what the UK Health Security Agency has described as an “unprecedented” outbreak. The spread has been linked to a Canterbury nightclub and infections with meningococcal B, which can lead to the development of meningitis.
This alarming situation in the UK serves as a stark reminder of the potential risks, even here in Australia. While not as common as seasonal flu, meningococcal B and its associated meningitis can have devastating consequences. We’ve seen concerning instances locally, with Queensland woman Anna Gallo recently falling into a coma after contracting the disease overseas. This occurred just months after Australian cricket star Damien Martyn underwent treatment for meningitis.
To understand the implications for Australia, it’s crucial to delve into what these diseases are, their symptoms, the potential long-term effects, and how we can protect ourselves.
Understanding Meningitis and Meningococcal B
Meningitis, at its core, is an inflammation of the protective membranes that surround the brain and spinal cord. In the context of the recent UK outbreak, this inflammation was triggered by meningococcal B bacteria.
Meningococcal B is a particularly concerning strain because it can lead to both meningococcal disease and meningitis. Transmission typically occurs through prolonged, close contact with an infected individual. This can happen via:
- Coughing and sneezing: Droplets containing the bacteria can be expelled into the air.
- Kissing: Direct contact can facilitate the transfer of bacteria.
- Sharing personal items: Although less common, sharing utensils or drinks could pose a risk.
Professor Paul Griffin, Director of Infectious Diseases at Mater Health Services in Brisbane, clarifies that meningococcal B isn’t as easily spread as the common cold or flu. “It is harder to spread than those viral infections, but having said that, it can spread fairly readily given the right circumstances,” he explains. While it can affect people of all ages, the disease is observed more frequently in infants and young children, presenting a slightly higher risk to this demographic.
Recognising the Symptoms: Early Detection is Key
The initial signs of meningococcal B can be deceptive, often mimicking those of a common viral infection. Professor Griffin notes, “It can include respiratory symptoms that might mimic another respiratory virus like the flu.”
However, if left unchecked, the disease can rapidly progress. “Then, we’ll very rapidly progress to a potentially severe headache, specific symptoms of that inflammation of the brain,” he warns.
As the illness advances, more severe symptoms emerge, which can include:
- Severe headache: Often described as the worst headache ever experienced.
- Neck stiffness: Difficulty in bending the neck forward.
- Sensitivity to light (photophobia): Discomfort or pain from bright lights.
- Fever: A significant rise in body temperature.
- Rash: A characteristic rash, often appearing as small, red or purple spots that don’t fade when pressed (a non-blanching rash). This is a critical sign and requires immediate medical attention.
- Vomiting and nausea.
- Drowsiness and confusion.
Professor Griffin stresses the urgency of seeking medical help: “By the time you have those more specific signs and symptoms, it’s potentially too late.”
The Lingering Shadow: Long-Term Consequences of Meningococcal Disease
The impact of meningococcal disease, particularly when it leads to meningitis, can be profound and long-lasting. According to the Australian Institute of Health and Welfare, a concerning statistic is that up to 10% of patients with meningococcal disease will succumb to the infection. For those who survive, the battle isn’t always over, with up to one in five experiencing significant long-term health problems.
These debilitating effects can include:
- Kidney damage: Impaired kidney function.
- Loss of digits or limbs: Amputation may be necessary due to necrotic lesions, patches of dead or dying tissue, as experienced by Anna Gallo.
- Neurological consequences: These can manifest as seizures, chronic headaches, and cognitive impairments.
- Sensory loss: Significant hearing loss and vision impairment, including blindness.
The need for ongoing care for survivors can be substantial. Professor Griffin highlights that “those who survived the disease would potentially require high levels of care for the rest of their lives.” Anna Gallo’s experience underscores this, as the permanent scarring from necrotic lesions serves as a constant reminder of the disease’s severity.
Treatment and the Power of Prevention
Prompt medical intervention is critical when meningococcal disease is suspected. In the UK, the Health Security Agency has been administering antibiotics to those exposed, a strategy aimed at preventing the spread. “The earlier the antibiotics can be given the better the outcomes,” Professor Griffin advises.
He strongly urges anyone experiencing non-specific symptoms, such as a cough, fever, joint pain, or headache, to get tested. Early diagnosis allows for treatment before the infection progresses to its more severe stages. The World Health Organization unequivocally states that meningitis is a medical emergency requiring immediate attention at a healthcare facility.
The case of Damien Martyn, who was placed in a medically induced coma and told he had only a 50-50 chance of survival, illustrates the life-threatening nature of the disease.
However, the most effective strategy against meningococcal and meningitis is vaccination. While vaccines exist for meningococcal strains A, C, W, and Y, the meningococcal B vaccine is not universally available for free across Australia. Professor Griffin attributes this to an inconsistent national policy regarding Meningococcal B vaccinations. “This vaccine is about preventing the really terrible consequences that happen due to what is a rare infection, but a very serious one,” he asserts.
Currently, only South Australia and Queensland offer free meningococcal B vaccinations. For travellers, especially those planning trips to sub-Saharan Africa, the Royal Australian College of General Practitioners recommends getting vaccinated.
Australia’s Vulnerability and the Call for Vigilance
Professor Griffin expressed a real concern that Australia could indeed experience a meningococcal outbreak similar to the one in the UK. He points to a lack of public awareness surrounding meningococcal B and the importance of vaccination as key contributing factors. “A lot of people haven’t seen a person with it or experienced it for themselves, so they think, ‘Oh, that won’t happen to me,'” he says. This complacency, he warns, is dangerous. “It’s a terrible tragedy when we see such devastating outcomes come from vaccine-preventable diseases.”
With declining vaccination rates globally and resurgent outbreaks of diseases like measles, maintaining vigilance is paramount. Professor Griffin’s advice is clear: “I would encourage, essentially, everybody to seek advice before you travel.” By taking proactive steps and staying informed, Australia can significantly reduce the risk of importing and spreading such serious infectious diseases. “The more we can do that … the less likely we are of bringing those sorts of issues onto our shores.”
